CRYO-CELL INTERNATIONAL, INC. Marketable Securities (Current)
CRYO-CELL INTERNATIONAL, INC. (CCEL) had Marketable Securities (Current) of $2.65 million as of 2026-05-31, per its 10-Q filed 2026-07-15.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-07-15
- 2026-05-31: Marketable Securities, Current $2.65M.
- 2026-02-28: Marketable Securities, Current $2.65M.
- 2025-11-30: Marketable Securities, Current $2.98M.
- 2025-08-31: Marketable Securities, Current $2.96M.
| Period end | Marketable Securities, Current |
|---|---|
| 2026-05-31 | $2.65M 10-Q · filed 2026-07-15 |
| 2026-02-28 | $2.65M 10-Q · filed 2026-04-14 |
| 2025-11-30 | $2.98M 10-Q · filed 2026-07-15 |
| 2025-08-31 | $2.96M 10-Q · filed 2025-10-15 |
| 2025-05-31 | $4.29M 10-Q · filed 2025-07-15 |
| 2025-02-28 | $3.26M 10-Q · filed 2025-04-14 |
| 2024-11-30 | $2.94M 10-K · filed 2026-02-27 |
| 2024-08-31 | $1.93M 10-Q · filed 2024-10-15 |
| 2024-05-31 | $1.06M 10-Q · filed 2024-07-15 |
| 2024-02-29 | $732.48K 10-Q · filed 2024-04-15 |
| 2023-11-30 | $574.18K 10-K · filed 2025-02-28 |
| 2023-08-31 | $623.49K 10-Q · filed 2023-10-12 |
| 2023-05-31 | $568.18K 10-Q · filed 2023-07-14 |
| 2023-02-28 | $840.28K 10-Q · filed 2023-04-21 |
| 2022-11-30 | $17.62K 10-K · filed 2024-02-28 |
| 2022-08-31 | $38.70K 10-Q · filed 2022-10-18 |
| 2022-05-31 | $63.13K 10-Q · filed 2022-07-11 |
| 2022-02-28 | $472.37K 10-Q · filed 2022-04-13 |
| 2021-11-30 | $75.41K 10-K · filed 2023-02-28 |
| 2021-08-31 | $74.12K 10-Q · filed 2021-10-15 |
| 2021-05-31 | $73.39K 10-Q · filed 2021-07-15 |
| 2021-02-28 | $85.90K 10-Q · filed 2021-04-14 |
| 2020-11-30 | $88.48K 10-K · filed 2022-02-22 |
| 2020-08-31 | $62.72K 10-Q · filed 2020-10-15 |
| 2020-05-31 | $905.43K 10-Q · filed 2020-07-10 |
| 2020-02-29 | $959.00K 10-Q · filed 2020-04-14 |
| 2019-11-30 | $904.05K 10-K · filed 2021-03-01 |
| 2019-08-31 | $874.69K 10-Q · filed 2019-10-15 |
| 2019-05-31 | $839.81K 10-Q · filed 2019-07-15 |
| 2019-02-28 | $808.51K 10-Q · filed 2019-04-15 |
| 2018-11-30 | $875.69K 10-K · filed 2020-02-28 |
| 2018-08-31 | $949.76K 10-Q · filed 2018-10-15 |
| 2018-05-31 | $572.61K 10-Q · filed 2018-07-16 |
| 2018-02-28 | $586.23K 10-Q · filed 2018-04-16 |
| 2017-11-30 | $439.32K 10-K · filed 2019-02-28 |
| 2017-08-31 | $523.88K 10-Q · filed 2017-10-16 |
| 2017-05-31 | $478.34K 10-Q · filed 2017-07-07 |
| 2017-02-28 | $476.46K 10-Q · filed 2017-04-13 |
| 2016-11-30 | $624.22K 10-K · filed 2018-02-28 |
| 2016-08-31 | $630.02K 10-Q · filed 2016-10-17 |
| 2016-05-31 | $673.78K 10-Q · filed 2016-07-11 |
| 2016-02-29 | $617.11K 10-Q · filed 2016-04-14 |
| 2015-11-30 | $610.42K 10-K · filed 2017-02-28 |
| 2015-08-31 | $460.51K 10-Q · filed 2015-10-15 |
| 2015-05-31 | $532.37K 10-Q · filed 2015-07-15 |
| 2015-02-28 | $98.26K 10-Q · filed 2015-04-14 |
| 2014-11-30 | $102.67K 10-K · filed 2016-02-29 |
| 2014-08-31 | $122.66K 10-Q · filed 2014-10-15 |
| 2014-05-31 | $140.56K 10-Q · filed 2014-07-03 |
| 2013-11-30 | $37.91K 10-K · filed 2015-03-02 |
| 2011-11-30 | $1.00M 10-K · filed 2013-02-28 |
| 2011-08-31 | $1.00M 10-Q/A · filed 2011-11-07 |
| 2010-11-30 | $1.13M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |